In a filing to national Stock Exchange on 14th June 2016 at 11:08 hours, Ajanta Pharma announced the launch of anti-dementia Memantine Hydrochloride tablets in the US market. In the filing, Ajanta Pharma announced "the launch of Memantine Hydrochloride tablets in the US market through its wholly-owned subsidiary Ajanta Pharma USA Inc". Memantine Hydrochloride tablets are anti-dementi